DrugPatentWatch Database Preview
Adamas Pharma Company Profile
What is the competitive landscape for ADAMAS PHARMA, and when can generic versions of ADAMAS PHARMA drugs launch?
ADAMAS PHARMA has one approved drug.
There are fourteen US patents protecting ADAMAS PHARMA drugs.
There are twenty-three patent family members on ADAMAS PHARMA drugs in seven countries.
Summary for Adamas Pharma
| International Patents: | 23 |
| US Patents: | 14 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Adamas Pharma: | See patent lawsuits for Adamas Pharma |
| PTAB Cases with Adamas Pharma as patent owner: | See PTAB cases with Adamas Pharma as patent owner |
Drugs and US Patents for Adamas Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-001 | Aug 24, 2017 | RX | Yes | No | 9,867,793 | Start Trial | Start Trial | ||||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-001 | Aug 24, 2017 | RX | Yes | No | 9,867,791 | Start Trial | Start Trial | ||||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-001 | Aug 24, 2017 | RX | Yes | No | 8,895,616 | Start Trial | Start Trial | ||||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-001 | Aug 24, 2017 | RX | Yes | No | 9,877,933 | Start Trial | Start Trial | ||||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-001 | Aug 24, 2017 | RX | Yes | No | 8,895,614 | Start Trial | Y | Start Trial | |||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-002 | Aug 24, 2017 | RX | Yes | Yes | 8,895,618 | Start Trial | Y | Start Trial | |||
| Adamas Pharma | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-002 | Aug 24, 2017 | RX | Yes | Yes | 8,895,617 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Adamas Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2015202356 | Start Trial |
| Canada | 2588296 | Start Trial |
| Japan | 2015131818 | Start Trial |
| European Patent Office | 1845968 | Start Trial |
| Japan | 6038203 | Start Trial |
| Mexico | 2012006320 | Start Trial |
| Japan | 2013512919 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
